The previous page is sending you to https://www.businesswire.com/news/home/20211031005023/en/New-Research-for-KEYTRUDA%C2%AE-pembrolizumab-at-Society-for-Melanoma-Research-SMR-2021-Congress-Reinforces-Merck%E2%80%99s-Commitment-to-Patients-With-Melanoma-Across-Stages-of-Disease.

 If you do not want to visit that page, you can return to the previous page.